INT54238

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.32
First Reported 1993
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 7
Total Number 7
Disease Relevance 3.17
Pain Relevance 1.43

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (UFM1) cytoplasm (UFM1)
Anatomy Link Frequency
plasma 3
chondrocytes 1
UFM1 (Homo sapiens)
Pain Link Frequency Relevance Heat
acular 21 99.68 Very High Very High Very High
Dopamine 2 86.64 High High
Clonidine 2 81.12 Quite High
Pain 35 79.52 Quite High
bradykinin 50 76.16 Quite High
Central nervous system 2 74.56 Quite High
Osteoarthritis 89 67.32 Quite High
complementary and alternative medicine 29 54.44 Quite High
Acute pain 1 50.00 Quite Low
imagery 18 45.36 Quite Low
Disease Link Frequency Relevance Heat
Renal Failure 6 99.68 Very High Very High Very High
Hypertension 6 98.84 Very High Very High Very High
Anaerobic Bacterial Infections 10 97.66 Very High Very High Very High
Obesity 14 90.16 High High
Injury 39 85.44 High High
Pain 35 79.52 Quite High
Disease 45 75.00 Quite High
Osteoarthritis 45 67.32 Quite High
Parkinson's Disease 2 60.72 Quite High
Knee Osteoarthritis 48 58.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Cerebrospinal fluid chromogranin A was not changed (P > 0.1) in essential hypertension (84.2 +/- 14.0 ng/ml) or renal failure (72.2 +/- 13.4 ng/ml), despite a marked (7.1-fold; P < 0.001) increase in plasma chromogranin A in renal failure, and a modest (1.5-fold; P = 0.004) increase in plasma chromogranin A in essential hypertension.
Positive_regulation (increase) of 1.5-fold in plasma associated with renal failure and hypertension
1) Confidence 0.32 Published 1993 Journal Neuroscience Section Abstract Doc Link 7904334 Disease Relevance 0.69 Pain Relevance 0.15
Cerebrospinal fluid chromogranin A was not changed (P > 0.1) in essential hypertension (84.2 +/- 14.0 ng/ml) or renal failure (72.2 +/- 13.4 ng/ml), despite a marked (7.1-fold; P < 0.001) increase in plasma chromogranin A in renal failure, and a modest (1.5-fold; P = 0.004) increase in plasma chromogranin A in essential hypertension.
Neg (not) Positive_regulation (increase) of 7.1-fold in plasma associated with renal failure and hypertension
2) Confidence 0.32 Published 1993 Journal Neuroscience Section Abstract Doc Link 7904334 Disease Relevance 0.71 Pain Relevance 0.16
Compared to placebo, tetanus toxoid administration stimulated significant increases in plasma ACTH and serum cortisol, with the maximum cortisol increase of 1.6-fold occurring 4.5 h after drug administration.
Positive_regulation (increase) of 1.6-fold in plasma associated with anaerobic bacterial infections
3) Confidence 0.18 Published 1998 Journal J. Clin. Endocrinol. Metab. Section Abstract Doc Link 9589678 Disease Relevance 0.72 Pain Relevance 0
Physiological tonicity also upregulated COL2 protein expression (Figure 2e): levels significantly increased (between 1.5-fold and 2.2-fold) in P0, P1 and P2 chondrocytes.
Positive_regulation (increased) of 1.5-fold in chondrocytes
4) Confidence 0.02 Published 2010 Journal Arthritis Res Ther Section Body Doc Link PMC2911888 Disease Relevance 0.13 Pain Relevance 0.06
Lee et al. reported that TCM outpatient use rate increased 1.75-fold from 1983 to 1988 because of the opening of labour insurance coverage in Taiwan [14].
Positive_regulation (increased) of 1.75-fold
5) Confidence 0.01 Published 2007 Journal BMC Health Serv Res Section Body Doc Link PMC1810531 Disease Relevance 0 Pain Relevance 0.05
For Ln-BSAP, there was a modest nonsignificant association, with the odds of a BML being present increasing 1.4-fold per 1 standard deviation increase in the Ln-BSAP.
Positive_regulation (increasing) of 1.4-fold
6) Confidence 0.01 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2575616 Disease Relevance 0.23 Pain Relevance 0.03
Similarly, BDKRB2 was 2-fold upregulated in the placebo treated group (p < 0.0001; paired t-test; n = 15) and 1.9-fold upregulated in the ketorolac treatment group (p < 0.0001; paired t-test; n = 15).
Positive_regulation (upregulated) of 1.9-fold associated with acular
7) Confidence 0.01 Published 2010 Journal Mol Pain Section Body Doc Link PMC2834653 Disease Relevance 0.69 Pain Relevance 0.97

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox